-
Product Insights
Bacteriuria Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Bacteriuria Global Clinical Trials Review, H1, 2016" provides an overview of Bacteriuria clinical trials scenario. This report provides top line data relating to the clinical trials on Bacteriuria. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Impetigo Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Impetigo Global Clinical Trials Review, H1, 2016" provides an overview of Impetigo clinical trials scenario. This report provides top line data relating to the clinical trials on Impetigo. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Cellulitis Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Cellulitis Global Clinical Trials Review, H1, 2016" provides an overview of Cellulitis clinical trials scenario. This report provides top line data relating to the clinical trials on Cellulitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Tuberculosis Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Tuberculosis Global Clinical Trials Review, H1, 2016" provides an overview of Tuberculosis clinical trials scenario. This report provides top line data relating to the clinical trials on Tuberculosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Fungemia Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Fungemia Global Clinical Trials Review, H1, 2016" provides an overview of Fungemia clinical trials scenario. This report provides top line data relating to the clinical trials on Fungemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Cryptococcosis Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Cryptococcosis Global Clinical Trials Review, H1, 2016" provides an overview of Cryptococcosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cryptococcosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Dermatomycoses Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Dermatomycoses Global Clinical Trials Review, H1, 2016" provides an overview of Dermatomycoses clinical trials scenario. This report provides top line data relating to the clinical trials on Dermatomycoses. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Endotoxemia Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Endotoxemia Global Clinical Trials Review, H1, 2016" provides an overview of Endotoxemia clinical trials scenario. This report provides top line data relating to the clinical trials on Endotoxemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
EpiCast Report: Meningococcal Disease – Epidemiology Forecast to 2025
Invasive meningococcal disease (IMD) is a life-threatening condition caused by the bacterium Neisseria meningitidis (N. meningitidis), an encapsulated gram-negative diplococcus that is a pathogen exclusive to humans. N. meningitidis is carried harmlessly in the nasopharynx of approximately 5?11% of adults and up to 25% of adolescents. Life-threatening disease occurs when the bacterium invades body tissue, which most commonly manifests as meningitis or septicemia. The disease is transmitted via respiratory droplets, through close or prolonged contact with an infected individual. N....
-
Product Insights
Aspergillosis Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Aspergillosis Global Clinical Trials Review, H1, 2017" provides an overview of Aspergillosis clinical trials scenario. This report provides top line data relating to the clinical trials on Aspergillosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.